Does B Cell Receptor Signaling in Chronic Lymphocytic Leukaemia Cells Differ from That in Other B Cell Types?
Chronic lymphocytic leukaemia (CLL) is an incurable malignancy of mature B cells. CLL is important clinically in Western countries because of its commonality and because of the significant morbidity and mortality associated with the progressive form of this incurable disease. The B cell receptor (BC...
Saved in:
| Main Author: | Joseph R. Slupsky |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Scientifica |
| Online Access: | http://dx.doi.org/10.1155/2014/208928 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characterisation of Cytotoxicity-Related Receptors on γδ T Cells in Chronic Lymphocytic Leukaemia
by: Michał Zarobkiewicz, et al.
Published: (2025-03-01) -
Influence of polyfunctional Tbet+ T cells on specific clinical events in chronic lymphocytic leukaemia
by: Yeong Jer Lim, et al.
Published: (2025-04-01) -
Dasatinib inhibits CXCR4 signaling in chronic lymphocytic leukaemia cells and impairs migration towards CXCL12.
by: Alison M McCaig, et al.
Published: (2012-01-01) -
Acute B-cell lymphoblastic leukaemia presenting as acute hepatitis
by: I. Jenosha, et al.
Published: (2025-03-01) -
Successful Control of Hepatitis B Virus Reactivation following Restart of Ibrutinib in Chronic Lymphocytic Leukaemia
by: Sara Kristina Viberg Tjønnfjord, et al.
Published: (2021-01-01)